SCHEMBL27831701

SCHEMBL27831701

COC(=O)c1ccccc1C=Cc1ccc(F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.59
SLC6A4 P31645 1/20 0.55
SLC6A3 Q01959 1/20 0.55
NFE2L2 Q16236 5/20 0.51
SNCA P37840 2/20 0.51
CYP1A2 P05177 3/20 0.50
CYP2C19 P33261 2/20 0.50
TSHR P16473 2/20 0.50
CYP2D6 P10635 1/20 0.50
MAOA P21397 3/20 0.48
MAOB P27338 3/20 0.48
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29227737 0.87 BACE1 (0.61) BACE1SLC6A3NFE2L2SNCACYP1A2
SCHEMBL2658197 0.87 BACE1 (0.61) BACE1SLC6A3NFE2L2SNCACYP1A2
SCHEMBL30423635 0.87 BACE1 (0.61) BACE1SLC6A3NFE2L2SNCACYP1A2
SCHEMBL2658196 0.87 BACE1 (0.61) BACE1SLC6A3NFE2L2SNCACYP1A2
SCHEMBL69552 0.85 BACE1 (0.60) BACE1SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL69553 0.85 BACE1 (0.60) BACE1SLC6A4SLC6A3TSHRALDH1A1
SCHEMBL9375045 0.85 BACE1 (0.59) BACE1SLC6A3SNCACYP1A2CYP2C19
SCHEMBL29054162 0.85 BACE1 (0.59) BACE1SLC6A4SLC6A3SNCACYP1A2
SCHEMBL5332771 0.85 BACE1 (0.59) BACE1NFE2L2SNCACYP2C19CYP2D6
SCHEMBL9375048 0.85 BACE1 (0.59) BACE1SLC6A3SNCACYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102307872-A BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBOTT LAB 2012-01-04 CN disclosed
CN-102282129-A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 2011-12-14 CN disclosed